FDA`s Arthritis Advisory Committee Recommends Approval of Celltrion`s CT-P13, a Proposed Biosimilar Infliximab, for … – Business Wire (press release)

February 11, 2016 by  
Filed under Osteo-Arthritis News


Bidness ETC

FDA's Arthritis Advisory Committee Recommends Approval of Celltrion's CT-P13, a Proposed Biosimilar Infliximab, for
Business Wire (press release)
INCHEON, South Korea–(BUSINESS WIRE)–Celltrion, a global biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) Arthritis Advisory Committee recommended approval of all indications for CT-P13, a proposed …
FDA Arthritis Advisory Committee votes in favor of biosimilar to infliximabHealio
BPC Statement on FDA Arthritis Advisory Committee MeetingPR Newswire (press release)
The FDA Arthritis Advisory Committee Voted For The Biosimilar Infliximab From Pfizer Inc. (NYSE:PFE)fdanewsalert.com

all 144 news articles »

More Info: Click here

“Finally, you can have the same Revolutionary Yoga Program top athletes use for TOTAL mind-body fitness ... in just 30 minutes a day!”

Speak Your Mind

Tell us what you're thinking...
and oh, if you want a pic to show with your comment, go get a gravatar!

This blog is kept spam free by WP-SpamFree.

Access denied for user ''@'localhost' (using password: NO)